OIM
Oracle Investment Management Portfolio holdings
AUM
$116M
1-Year Return
84.31%
This Quarter Return
+0.96%
1 Year Return
+84.31%
3 Year Return
+539.5%
5 Year Return
+791.07%
10 Year Return
+13,222.09%
AUM
$824M
AUM Growth
-$51.7M
(-5.9%)
Cap. Flow
-$27.7M
Cap. Flow
% of AUM
-3.36%
Top 10 Holdings %
Top 10 Hldgs %
74.72%
Holding
32
New
1
Increased
8
Reduced
14
Closed
2
Top Buys
| 1 |
AXDX
Accelerate Diagnostics
AXDX
|
$16M |
| 2 |
BLUE
bluebird bio
BLUE
|
$6.9M |
| 3 |
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
|
$3.79M |
| 4 |
Accuray
ARAY
|
$3.31M |
| 5 |
Pacific Biosciences
PACB
|
$2.64M |
Top Sells
| 1 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$16M |
| 2 |
Tenet Healthcare
THC
|
$11.1M |
| 3 |
THOR
THORATEC CORPORATION
THOR
|
$10.1M |
| 4 |
QuidelOrtho
QDEL
|
$7.55M |
| 5 |
Precigen
PGEN
|
$4.56M |
Sector Composition
| 1 | Healthcare | 76.93% |
| 2 | Consumer Staples | 0.18% |
| 3 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biogen
BIIB
$20.5B
| $2.44M | 0.3% |
7,723
-3,807
| -33% | -$1.2M |
|
|
YTEN
27
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
| $1.44M | 0.18% |
29
| – | – |
|
28
Tonix Pharmaceuticals
TNXP
$231M
| – | – |
0
| – | – |
|
|
ONCT
29
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $366K | 0.04% |
189
-167
| -47% | -$323K |
|
|
LTS
30
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
| $352K | 0.04% |
111,789
-55,060
| -33% | -$173K |
|
31
Agios Pharmaceuticals
AGIO
$2.1B
| – | – |
-100,000
| Closed | -$3.92M |
|
|
ECYT
32
DELISTED
Endocyte, Inc. Common Stock
ECYT
| – | – |
-670,000
| Closed | -$16M |
|